GYKI-52895

From Wikipedia, the free encyclopedia
  (Redirected from GYKI-52,895)
Jump to: navigation, search
GYKI-52895
GYKI-52895.png
Systematic (IUPAC) name
4-{13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.03,7]tetradeca-1,3(7),8,10-tetraen-10-yl}aniline
Clinical data
Legal status
?
Identifiers
CAS number 869360-93-0
ATC code ?
PubChem CID 3539
ChemSpider 3418 YesY
KEGG C15094 YesY
Synonyms 4-(8,9-Dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine
Chemical data
Formula C17H17N3O2 
Mol. mass 295.34
 YesY (what is this?)  (verify)

GYKI-52895 is a drug which is a 2,3-benzodiazepine derivative. Unlike other similar drugs, GYKI-52895 is a selective dopamine reuptake inhibitor,[1][2] which presumably would produce stimulant effects in vivo.[original research?]

See also[edit]

References[edit]

  1. ^ Horváth K, Szabó H, Pátfalusi M, Berzsenyi P, Andrási F. Pharmacological Effects of GYKI 52895, a New Selective Dopamine Uptake Inhibitor. European Journal of Pharmacology. 1990; 183(4):1416-1417.
  2. ^ Huang CL, Chen HC, Huang NK, Yang DM, Kao LS, Chen JC, Lai HL, Chern Y. Modulation of Dopamine Transporter Activity by Nicotinic Acetylcholine Receptors and Membrane Depolarization in Rat Pheochromocytoma PC12 Cells. Journal of Neurochemistry. 1999; 72(6): 2437–2444.